VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
0.3180
-0.0045 (-1.40%)
At close: Aug 17, 2026, 4:00 PM EDT
0.3171
-0.0009 (-0.28%)
After-hours: Aug 17, 2026, 6:35 PM EDT
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of $1.11 million as of August 17, 2026. Its market cap has decreased by -76.85% in one year.
Market Cap
1.11M
Enterprise Value
-242.89K
1-Year Change
-76.85%
Ranking
Category
Stock Price
$0.32
ChartMarket Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from $11.20M to $1.11M, a decrease of -90.08%. That is a compound annual growth rate of -14.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 4.80M | 2.13% |
| Dec 31, 2025 | 4.70M | -33.80% |
| Dec 31, 2024 | 7.10M | -27.55% |
| Dec 29, 2023 | 9.80M | -20.33% |
| Dec 30, 2022 | 12.30M | -61.08% |
| Dec 31, 2021 | 31.60M | -61.84% |
| Dec 31, 2020 | 82.80M | 78.45% |
| Dec 31, 2019 | 46.40M | -58.16% |
| Dec 31, 2018 | 110.90M | -22.61% |
| Dec 29, 2017 | 143.30M | -59.30% |
| Dec 30, 2016 | 352.10M | 53.02% |
| Dec 31, 2015 | 230.10M | -60.58% |
| Dec 31, 2014 | 583.70M | -31.77% |
| Dec 31, 2013 | 855.50M | 600.66% |
| Dec 31, 2012 | 122.10M | 990.18% |
| Feb 14, 2012 | 11.20M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 2.26M |
| Azitra | 2.20M |
| Genprex | 2.03M |
| Decoy Therapeutics | 1.88M |
| CDT Equity | 1.86M |
| Calidi Biotherapeutics | 1.84M |
| Biodexa Pharmaceuticals | 1.54M |
| Matinas BioPharma Holdings | 1.47M |